(Date:3/15/2010)... seabirds, cover enormous distances during migration: the sooty shearwater, ... times on its travels. Despite this, relatively little is ... with that of their land-living counterparts. Scientists from the ... behaviour of thin-billed prions and discovered that the animals ... at a considerable distance from each other. Thus, it ...
(Date:3/15/2010)... paradigm changing discovery, Plasmodium vivax ( P. ... historically thought to be resistant to the disease, those ... on their red blood cells, according to researchers from ... and the Madagascar Ministry of Health. In a study ... the main malaria transmission areas of Madagascar, the researchers ...
(Date:3/15/2010)... An experimental oral drug has lowered blood sugar levels ... that the medication could someday be added to the ... this disease, according to new research. , The drug ... activity of a protein called macrophage migration inhibitory factor, ... of diseases because it is associated with the production ...
Breaking Biology News(10 mins):To the Antarctic or Brazil for new feathers 2To the Antarctic or Brazil for new feathers 3Duffy-negative blood types no longer protected from P. Vivax malaria 2Duffy-negative blood types no longer protected from P. Vivax malaria 3Study points to potential new drug for type 2 diabetes 2Study points to potential new drug for type 2 diabetes 3Study points to potential new drug for type 2 diabetes 4Jet Powered Mobility Scooter Revolutionizes Mobility Transportation 64495 1Jet Powered Mobility Scooter Revolutionizes Mobility Transportation 64495 2Jet Powered Mobility Scooter Revolutionizes Mobility Transportation 64495 3Siemens Taps Top Energy Expert as New Head of U S Business 64492 1Siemens Taps Top Energy Expert as New Head of U S Business 64492 2Siemens Taps Top Energy Expert as New Head of U S Business 64492 3APDA Launches First of its Kind Parkinsons Rehab Resource Center 64489 1APDA Launches First of its Kind Parkinsons Rehab Resource Center 64489 2APDA Launches First of its Kind Parkinsons Rehab Resource Center 64489 3... This release is available in German . ... new homes than in their place of origin. The reasons ... herbivores such as insects that first have to adapt to ... Helmholtz Centre for Environmental Research (UFZ) from their research on ...
... Leemor Joshua-Tor, Ph.D., a CSHL professor and Dean of ... a Howard Hughes Medical Institute (HHMI) Investigator. ... known and respected worldwide, is one of 56 new ... approximately 300 Investigators in the Institutes flagship program, who ...
... by UC San Diego chemists will be the basis ... of nitrogen-based explosives. , Contaminated fingerprints leave dark shadows ... One of the films can distinguish between different classes ... to help solve a crime, or prevent one. , ...
Other Biology News:When the butterfly bush blossoms 2When the butterfly bush blossoms 3Leemor Joshua-Tor, PhD, CSHL biologist and WSBS dean, is named an HHMI Investigator 2Leemor Joshua-Tor, PhD, CSHL biologist and WSBS dean, is named an HHMI Investigator 3Glowing films developed by UC San Diego chemists reveal traces of explosives 2(Date:3/14/2010)... researcher is biochemist Rudolf Jaenisch from the Massachusetts Institute of Technology . He is joined by scientists scattered from Ann Arbor ... ... , ... ... ...
(Date:3/12/2010)... and material testing, is taking strides to expand their Product and ... , ... Minneapolis, MN (PRWEB) March 12, 2010 -- ... is taking strides to expand their Product and Material Testing Division ... has been helping medical device manufacturers get to market for almost ...
(Date:3/11/2010)... 11 Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a five-day dosing regimen for Dacogen® (decitabine) ... ... , , ... ... ...
(Date:3/11/2010)... signed a definitive agreement with Elan Pharmaceuticals, Inc. (a subsidiary of Elan Corporation, plc) ( ELN) ("Elan") to acquire the analgesic therapy, PRIALT(R) (ziconotide intrathecal ... ... ... ... ...
Breaking Biology Technology:Thomson Reuters Names the World's 'Hottest' Researchers 2Thomson Reuters Names the World's 'Hottest' Researchers 3Thomson Reuters Names the World's 'Hottest' Researchers 4Thomson Reuters Names the World's 'Hottest' Researchers 5DDL Expands the Product & Material Testing Division 2DDL Expands the Product & Material Testing Division 3FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 2FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 3FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 4FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 5FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 6FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 7FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 8Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT(R) From Elan 2Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT(R) From Elan 3Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT(R) From Elan 4Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT(R) From Elan 5Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT(R) From Elan 6... -- Yongye Biotechnology,International, Inc. (OTC Bulletin Board: YGYB; ... distributor of nutrients for plants and,animals in the ... expand its,network of branded stores from 775 to ... In the quarter ended December 31, 2008, the ...
... Highlights Include: - Initiation of development activities ... Blockers- Receipt of GRAS (Generally Recognized As ... allows commercialization in the U.S. and elsewhere- ... SA- Continued activities to support regulatory filings ...
... RICHMOND, Va., Feb. 12 Insmed Inc.,(Nasdaq: ... on niche markets with unmet medical needs, announced today ... & Co., Inc. whereby Merck,through an affiliate, will purchase ... the terms of the agreement, Insmed will receive a,total ...
Other Biology Technology:Yongye Biotechnology International to Expand its Network of Branded Stores 2Yongye Biotechnology International to Expand its Network of Branded Stores 3Yongye Biotechnology International to Expand its Network of Branded Stores 4SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS 2SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS 3SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS 4SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS 5SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS 6SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS 7SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS 8SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS 9SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS 10SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS 11SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS 12SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS 13SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS 14Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million 2Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million 3Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million 4A simple, sensitive and reliable method for determining free sulfhydryl content in peptides, protein...
... EVO Clinical is Tecans open platform for ... quality, safety and performance in the clinical ... provided by flexible barcode reading and sample ... that the system complies with the IVD-Directive* ...
... StabilZyme HRP Conjugate Stabilizer is an aqueous ... and other non-toxic stabilizing chemicals in a ... 6.7. This product contains a ... 20 ppm Proclin 300 (Rohm and Haas ...
A collection of 42 spots with normal tissues from different organs of C57 mice, rat and human....
Biology Products:Biology NavigationMedical Navigation